Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vivacta Ltd.

Division of Novartis AG
www.vivacta.com

Latest From Orthovita Inc.

Spine Market: Pure Plays Continue to Grab Share

Amidst low growth and a potential rebound in the $9 billion global spine market, the pure-play spine companies, including NuVasive, Globus, K2M and LDR, continue to outperform and grab share from the diversified giants. Medtech Insight founder and former CEO Sharon O'Reilly reports on these companies and more from the 2015 North American Spine Society (NASS) conference in Chicago, where the latest news centered around ancillary approaches to fusion, patient-specific tools, robotics, biologics, expandable cages, MIS and cervical discs.

Medical Device Deals

Device Trends To Watch In 2012

For much of the device industry, 2011 was marked by continuing change across the medtech ecosystem, most notably in the economy, the regulatory process, and the financing/innovation model. For 2012, we predict more of the same: the only certainty is continuing uncertainty.

Medical Device Strategy

Market & Industry Briefs

Brief summaries of recent medtech market and industry developments.

Medical Device

Top Device Stories Of 2011: Living In A State Of Transition

EBI’s device team reviews of the top news stories in the medical device industry in 2011. Top stories include: 510(k) reform, user-fees, VC money dries up for medtech, hot clinical spaces of the year, where private investment dollars went in 2011, big changes at J&J, and the new physician/hospital alignments and their impact on the medical device industry.

Medical Device Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Biosensors
    • Chemistry, Immunoassay
    • Therapeutic Drug Monitoring
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • PanOpsys Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Novartis AG
  • Senior Management
  • Tim Carter, PhD, CEO
    Nigel Newton, Fin. Dir.
    Oliver Boucher, Chief Bus. Officer
    Steve Ross, Dir., R&D
  • Contact Info
  • Vivacta Ltd.
    Phone: (44) (0)1795 419400
    100 Guillat Av.
    Kent Science Pk
    Sittingbourne, Kent, ME9 8GU
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register